THE TIME IS NOW FOR EUROPEAN HTA: HOW WILL THE EVOLUTION OF EUROPEAN HTA IMPACT ACCESS TO INNOVATIVE MEDICINES?

被引：0
|
作者：
Laisne, E. [1 ]
Allen, N. [1 ]
Kolotourou, K. [1 ]
Sattler-Ermacora, P. [1 ]
Grosvenor, A. [1 ]
机构：
[1] Precis Xtract, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1195
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP301
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [1] The evolution of European HTA and access to innovative medicines
    Kolotourou, Kate
    Ermacora, Petra
    Grosvenor, Alexander
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (05) : 275 - 278
  • [2] EUnetHTA -: European network for HTA
    Maekelae, Marjukka
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 86 - 87
  • [3] THE IMPACT OF COVID-19 ON EUROPEAN HTA DECISIONS
    Watson, C.
    Petrie, J. L.
    Toomey, J. A.
    Shaw, C.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S183 - S183
  • [4] THE EVOLUTION AND COMPARISON OF HTA ASSESMENT ORGANISATIONS IN SELECTED EUROPEAN COUNTRIES
    Beletsi, A.
    Koutrafouri, V
    Karampli, E.
    Pavi, E.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A449 - A449
  • [5] DOES THE EUROPEAN UNION (EU) NEED EUROPEAN HTA OR EUROPEAN PROCUREMENT?
    Toumi, M.
    Remuzat, C.
    Auquier, P.
    Borrisov, B.
    Espin, J.
    Postma, M. J.
    Ruggeri, M.
    Wilk, N.
    Simoens, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S85 - S85
  • [6] TIME TO HTA ASSESSMENT COMPLETION BY HTA AGENCY ARCHETYPE: FIVE-YEAR REVIEW FOR 20 EUROPEAN COUNTRIES
    Izmirlieva, M. A.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S329 - S329
  • [7] INNOVATIVE ACCESS PATHWAYS FOR DIGITAL HEALTHCARE SOLUTIONS: LEARNINGS FROM A EUROPEAN ANALOGUE ANALYSIS FOR ASIAN HTA BODIES
    Barzey, V
    Brennan, J.
    Tutt, S.
    Cope, N.
    [J]. VALUE IN HEALTH, 2018, 21 : S73 - S73
  • [8] ACCESS TO MEDICINES IN THE UNITED KINGDOM: A REVIEW OF HTA DECISIONS FOR NEW MEDICINES
    Abbas, N.
    Hasan, S. S.
    Babar, Z. U. D.
    [J]. VALUE IN HEALTH, 2020, 23 : S665 - S665
  • [9] EXPEDITED REGULATORY REVIEW AND AUTHORISATION OF MEDICINES AND THEIR SUBSEQUENT APPRAISAL BY HTA AGENCIES IN THE EUROPEAN UNION
    McCarron, C.
    Griebsch, I
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A412 - A412
  • [10] HTA REQUIREMENTS IN CENTRAL EASTERN EUROPEAN COUNTRIES
    Augustynska, J.
    Skora, K.
    Leszczynska, A.
    Seweryn, M.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S326 - S326
12345